Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset (EUPA)
Early Prediction of Patient-related and Radiological Outcomes in Patients With Recent-onset Inflammatory Polyarthritis (EPA) Using Established and Novel Independent Predictors
Sponsor: Canadian Institutes of Health Research (CIHR)
A observational or N/A phase clinical study on Inflammatory Arthritis and Rheumatoid Arthritis, this trial is actively recruiting participants. The trial is conducted by Canadian Institutes of Health Research (CIHR) and has accumulated 16 data snapshots since 1998. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
Apr 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
-
Jun 2022 — Jan 2024 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
May 2019 — Nov 2020 [monthly]
Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
-
Aug 2017 — Jan 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jul 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Gilles Boire
- The Arthritis Society, Canada
For direct contact, visit the study record on ClinicalTrials.gov .